Ipca Laboratories Ltd.,fully-integrated pharmaceutical company, will announce its financial results on May 30 for the fourth quarter ended March 31, 2016.
Ipca Laboratories Ltd.,fully-integrated pharmaceutical company, will announce its financial results on May 30 for the fourth quarter ended March 31, 2016.
IIFL estimates the company’s net profit to increase to Rs.36 crore at 350% yoy and 56.5% qoq.
As per IIFL’s forecast, the company’s net revenue to go up to Rs.683 crore, increasing 8.8% qoq but declining 0.1% yoy.
Operating profit margin is likely to come in at 14.8%, with a yoy rise of 937 bps and 178 bps qoq.
Our preview coverage universe of 374 companies, representing ~75% of India’s equity market cap is expected to report 4.2% yoy drop in net profit in Q4 FY16. On a qoq basis, profits will rise by 17% on account of low base of preceding two quarters, which had witnessed sequential PAT declines.
Ipca Laboratories Ltd.,fully-integrated pharmaceutical company, will announce its financial results on May 30 for the fourth quarter ended March 31, 2016.IIFL estimates the company’s net profit to increase to Rs.36 crore at 350% yoy and 56.5% qoq.
As per IIFL’s forecast, the company’s net revenue to go up to Rs.683 crore, increasing 8.8% qoq but declining 0.1% yoy.
Operating profit margin is likely to come in at 14.8%, with a yoy rise of 937 bps and 178 bps qoq.
Our preview coverage universe of 374 companies, representing ~75% of India’s equity market cap is expected to report 4.2% yoy drop in net profit in Q4 FY16. On a qoq basis, profits will rise by 17% on account of low base of preceding two quarters, which had witnessed sequential PAT declines.
No comments:
Post a Comment